SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-039677
Filing Date
2019-02-14
Accepted
2019-02-14 10:29:02
Documents
1
Group Members
CHARLES I. CLOUGH, JR.CLOUGH CAPITAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d672808dsc13g.htm SC 13G 82679
  Complete submission text file 0001193125-19-039677.txt   84482
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Subject) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60635 | Film No.: 19602185
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE POST OFFICE SQUARE 40TH FLOOR BOSTON MA 02109
Business Address ONE POST OFFICE SQUARE 40TH FLOOR BOSTON MA 02109 6172043400
CLOUGH CAPITAL PARTNERS L P (Filed by) CIK: 0001276144 (see all company filings)

IRS No.: 043486480 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G